Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence

• Tipo: Outra Publicação em Revista Científica Internacional
• Data: 2020

Autores

Menditto, E (Autor) Outra; Orlando, V (Autor) Outra; De Rosa, G (Autor) Outra; Minghetti, P (Autor) Outra; Musazzi, UM (Autor) Outra; Cahir, C (Autor) Outra; Kurczewska Michalak, M (Autor) Outra; Kardas, P (Autor) Outra; Costa, E (Autor) FFUP; Sousa Lobo JM (Autor) FFUP; Almeida, IF (Autor) FFUP

Revista

Título: Pharmaceutics

Vol. 12

Página Final: 44

ISSN: 1999-4923

Editora: MDPI

Indexação

ISI Web of Knowledge - 37 Citações

Scopus - 43 Citações

Outras Informações

ID Authenticus: P-00R-N16

DOI: 10.3390/pharmaceutics12010044

Abstract (EN): Medication adherence is a growing concern for public health and poor adherence to therapy has been associated with poor health outcomes and higher costs for patients. Interventions for improving adherence need to consider the characteristics of the individual therapeutic regimens according to the needs of the patients. In particular, geriatric and paediatric populations as well as dermatological patients have special needs/preferences that should be considered when designing drug products. Patient Centric Drug Product Pharmaceutical Design (PCDPD) offers the opportunity to meet the needs and preferences of patients. Packaging, orodispersible formulations, fixed dose combinations products, multiparticulate formulations, topical formulations and 3D printing are of particular relevance in a PCDPD process. These will be addressed in this review as well as their impact on medication adherence.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 23